grant

Mechanisms That Control Antigen Receptor Variable Region Exon Assembly

Organization BOSTON CHILDREN'S HOSPITALLocation BOSTON, UNITED STATESPosted 1 Apr 1983Deadline 31 May 2027
NIHUS FederalResearch GrantFY2025Abelson Murine Leukemia Viral Oncogene HomologAddressAntibody RepertoireAntigen ReceptorsArchitectureAreaAssayB blood cellsB cellB cellsB-CellsB-LymphocytesB-cellBasal Transcription FactorBasal transcription factor genesBindingBioassayBiological AssayCancersCell BodyCellsChromatinChromatin LoopChromatin Loop DomainsChromosomesComplexDNA LoopDNA RecombinationDataDevelopmentDiffusionDistalElementsEndonuclease VEngineering / ArchitectureEventExonsFundingG1 ArrestG1 BlockGene TranscriptionGeneral Transcription Factor GeneGeneral Transcription FactorsGeneration of Antibody DiversityGenesGenetic RecombinationGenetic TranscriptionGoalsHumanIgKImmunoglobulin V(D)J RearrangementImmunologyIntercistronic RegionIntergenic RegionsLightLymphatic cellLymphocyteLymphocyticMalignant NeoplasmsMalignant TumorMapsMediatingMiceMice MammalsModern ManModificationMolecular InteractionMurineMusOncogene ABL1PatternPhotoradiationPlayPopulationProcessProteinsPublishingRNA ExpressionReactionRecombinationResolutionRoleScanningT-CellsT-LymphocyteTechnologyTestingTherapeutic antibodiesTrans-Acting FactorsTrans-ActivatorsTransactivatorsTranscriptionTranscription Factor Proto-OncogeneTranscription factor genesV(D)J RearrangementV(D)J RecombinationVDJ rearrangementVDJ recombinationWorkabl Oncogenecell population studycohesindevelopmentaldiffuseddiffusesdiffusingdiffusionsexperimentexperimental researchexperimental studyexperimentsgenome scalegenome-widegenomewidehigh throughput analysisin vivoinsightinterstitiallymph cellmalignancyneoplasm/cancernew technologynovel technologiesprogenitorprotein complexresolutionssocial rolethymus derived lymphocytetranscription factorv ablv-abl Genesv-abl Oncogenes
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

7. Project Summary/Abstract.
During the past funding period, we discovered that the cohesin-mediated loop extrusion process

involved in genome-wide modulation of chromosome architecture plays fundamental roles in V(D)J

recombination and the generation of antibody diversity. In developing progenitor B cells, we found that

cohesin-mediated loop extrusion linearly presents Ig heavy chain locus (Igh) VH, D, and JH gene segments to

the RAG endonuclease for V(D)J recombination. Our preliminary data indicate that long-range V(D)J

recombination in the Igk light chain locus may occur, at least in part, by a mechanistically distinct process from

that of Igh. We propose 2 specific aims to elucidate the potentially differential mechanisms of Igh versus Igk

long-range V(D)J recombination. A major hypothesis guiding Aim 1 and Aim2 studies is that Igh achieves long

range V(D)J recombination via linear RAG chromatin scanning that leads to predominantly deletional

recombination events. A major hypothesis to be tested for Aim 2 is that Igk is structurally-optimized to employ

a related loop extrusion-based mechanism that accommodates both robust deletional and inverted Vk-to-

Jk joining. These hypotheses are supported by a wealth of published and preliminary data derived in large part

from powerful new technologies that we developed during the current funding period. In particular we

developed LAM-HTGTS-V(D)J-Seq to assay V(D)J recombination with unprecedented sensitivity and LAM-3C-

HTGTS to map sequence interactions across chromatin domains at far higher resolution than prior assays. We

further developed G1-arrested, RAG inducible v-Abl transformed pro-B cell cell ("v-Abl cell") approaches to test

roles specific cis elements or trans-acting factors in long-range RAG chromatin-scanning through introduced

Igh or Igk locus modifications and/or targeted protein depletion. Aims 1 and 2 experiments together will

compare and contrast, in depth, the long-range mechanisms used by Igh and Igk to incorporate Vs into the

V(D)J recombination reaction. While most initial Aim 1 and 2 studies will employ v-Abl cells; all key results will

be confirmed/extended by studies of normal progenitor and precursor B cell populations These studies may

reveal new paradigms for understanding V(D)J recombination in vivo and illuminate the range of mechanisms

employed for long-range V(D)J recombination in antigen receptor loci. Addressing Aim 1 and 2 goals should

greatly impact the immunology field by providing major new insights into fundamental mechanisms that

establish highly diverse primary antibody repertoires. The studies proposed in Aim 1 and 2 will also further

elucidate how impediments in the scanning path focus cryptic RSS targets within impeded areas of chromatin

for incorporation into the RAG complex and subsequent rearrangement. Thus, these studies should provide

critical information for understanding how RAG targets cryptic RSSs in other genes and promotes common

translocations or interstitial deletions frequently found in B and T lymphocyte cancers of developing

lymphocytes in humans.

Grant Number: 4R01AI020047-43
NIH Institute/Center: NIH

Principal Investigator: Frederick Alt

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →